C12N 5/0031
Serum-free culture media
Official title: {Serum-free culture media}
C12N5/0031 (Serum-free culture media) appears on 119 US grants and 235 published applications in this corpus.
Search patents in C12N- Granted patents
- 119
- Published applications
- 235
- Assignees
- 111
- Inventors
- 447
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 1 | 2 |
| 2008 | 0 | 3 |
| 2009 | 1 | 2 |
| 2010 | 1 | 4 |
| 2011 | 2 | 3 |
| 2012 | 5 | 4 |
| 2013 | 1 | 6 |
| 2014 | 4 | 10 |
| 2015 | 10 | 8 |
| 2016 | 8 | 5 |
| 2017 | 2 | 5 |
| 2018 | 3 | 6 |
| 2019 | 4 | 12 |
| 2020 | 4 | 18 |
| 2021 | 12 | 29 |
| 2022 | 19 | 31 |
| 2023 | 15 | 30 |
| 2024 | 12 | 25 |
| 2025 | 10 | 15 |
| 2026 | 5 | 14 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods of preconditioning vascular cells for transduction, methods of transduction and methods of preserving transduced cells4 Aug 2026US 12,698,477 B2Vessi Therapeutics Ltd
- Method for producing composition containing polypeptide with suppressed coloring10 Mar 2026US 12,571,018 B2Chugai Seiyaku Kabushiki Kaisha
- Methods and compositions for delivery of biotin to mitochondria24 Feb 2026US 12,558,346 B2Social Profit Network
- Serum-free media formulation for culturing cells and methods of use thereof17 Feb 2026US 12,553,024 B2Juno Therapeutics, Inc.
- Primary gastrointestinal stromal tumor cell culture medium, culture method and application thereof6 Jan 2026US 12,517,114 B2Precedo Pharmaceuticals Co., Ltd
- Anti-vegf protein compositions and methods for producing the same8 Oct 2026US 2026/0308231 A1Regeneron Pharmaceuticals, Inc.
- Anti-vegf protein compositions and methods for producing the same8 Oct 2026US 2026/0308232 A1Regeneron Pharmaceuticals, Inc.
- Anti-vegf protein compositions and methods for producing the same8 Oct 2026US 2026/0308233 A1Regeneron Pharmaceuticals, Inc.
- Anti-vegf protein compositions and methods for producing the same24 Sep 2026US 2026/0285940 A1Regeneron Pharmaceuticals, Inc.
- Application of a brain organoid model for simulating the damage of environmental pollutants to brain development during embryonic period24 Sep 2026US 2026/0287574 A1Tianjin University
Most cited
By later US patents
- Fed-batch cell culture methods using non-animal-based hydrolysates79US 8,093,045 B2Abbott Laboratories · 2012
- Methods of producing anti-TNF-alpha antibodies in mammalian cell culture54US 8,663,945 B2AbbVie Inc. · 2014
- Fed-batch method of making human anti-TNF-alpha antibody42US 8,906,646 B2AbbVie Inc. · 2014
- Methods of producing adalimumab24US 9,284,371 B2AbbVie Inc. · 2016
- Methods of culturing cells in a medium comprising transforming growth factor beta 1 and basic fibroblast growth factor20US 8,563,311 B2Technion Research & Development Foundation Limited · 2013